ARTV vs XRAY · $37.3M cap vs rev $1.78B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
ARTV currently screens at market cap $37.3M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the ARTV and XRAY stock pages for the full models.
Not investment advice.